Objective: This study aimed to assess prognosis of isolated local recurrence (ILR) of renal cell carcinoma (RCC) after radical nephrectomy (RN). Patients and Methods: This retrospective study involved 22 cases (16 men and 6 women) of ILR from two centers with a mean age of 60.1 ± 8.5 years. All cases were managed surgically. Results: Primary tumors were mainly clear cell carcinoma (n = 17). Nine patients had T3 and T4 tumors. Local recurrence involved mainly the operative bed (n = 17); 4 among them had nodal recurrence as well. The median interval to local recurrence was 13.5 months (7-25 months). Stages T3 and T4 were significantly associated with shorter interval. Complete excision was possible in 9 patients (41%); 8 tumors were irresectable. It was associated with significantly higher overall and median disease-free survival (DFS). Advanced disease stage (p = 0.002) and shorter interval to recurrence (p < 0.001) were associated with higher proportion of incomplete excision. The median overall survival and DFS were 15 months (95% CI: 4.4-25.6) and 10 months (95% CI: 4.5-15.5), respectively. Overall and DF survival were significantly better in patients with nodal recurrence only, complete excision of the recurrence and interval from nephrectomy to recurrence >15 months. Conclusion: ILR after radical nephrectomy for RCC is more common with more advanced stages, where interval to recurrence tends to be shorter. The management should be surgical, which was possible in nearly 60% of cases. Complete excision was associated with better overall and disease free survival.
Introduction
Renal tumors account for nearly 2% of new cancer cases and are the 7th leading cause of death due to cancer [1] . More than 80% of kidney cancers are renal cell carcinoma (RCC) [2] . RCC is the most common malignancy arising in the renal parenchyma [3] . Incidence of RCC is higher in Europe and North America compared to Asia and Africa. In men, the incidence in developing countries was nearly half of that in developed countries. Jemal et al. reported the cumulative risk of RCC in developing countries of 0.03% compared to 1.4% in developed countries [4] .
Approximately 30% of patients with RCC present with locally advanced or metastatic disease [5] . Lymph node involvement is associated with a 5-year survival rate of 5-30% [6] . Patients with lymphadenopathy are 3-4 times more likely to have distant metastasis [7] . About 13% of patients present with metastatic disease at the time of diagnosis [8] .
Surgical treatment remains the only effective therapy for localized renal cell carcinoma [9] . Systemic medical methods of treating metastatic renal cell carcinoma have limited efficacy and are under evaluation. However, the past 10 years have shown a dramatic increase in the development of new agents for the treatment of advanced RCC. New agents have been approved for this disease [10] .
Modern imaging techniques and strict follow-up protocols have shown that loco-regional recurrence will occur in about 2% of patients after radical nephrectomy for localized RCC [9, 11] . Recurrent lesions may affect the ipsilateral adrenal gland, inadequately excised regional lymph nodes or the renal bed. Unintended perioperative implantation of tumor may cause local relapse [12] .
The isolated local recurrence of RCC after radical nephrectomy creates a difficult therapeutic decision because these patients are at high risk of distant metastatic disease [13] . Surgical treatment of local recurrences often conveys significant perioperative morbidity [14, 15] . Surgical removal of local recurrence in the absence of metastatic disease appears to be the only theoretically curative treatment option [9] .
However, there is no standard treatment for this rare condition. Relatively few series of treatment for local recurrence of kidney cancer have been published. Thus, we designed this study to assess the prognosis of isolated loco-regional recurrences after radical nephrectomy for RCC.
Patients and methods
This retrospective study reviewed databases of surgical departments at the National Cancer Institute (NCI), Cairo University and in Fayoum Teaching Hospital, Fayoum University between March 2004 and January 2012. The study identified 22 cases (16 men and 6 women) of isolated locoregional recurrences after radical nephrectomy for unilateral localized RCC. Patients with distant metastases were excluded by a work-up of bone scan, CT of the chest, abdomen and pelvis and PET CT in some cases. The total number of radical nephrectomies were 626 including cases operated in the NCI and Fayoum Teaching Hospital in addition to cases referred to the NCI with recurrence.
Data retrieved included initial pathological type, disease stage, histological grade, location of recurrence and excision of recurrence. Overall and disease free survival after excision of recurrence were calculated. Overall survival (OS) was calculated from the date of diagnosis of local recurrence to the date of death or last follow up visit. Disease-free survival (DFS) was calculated from the date of curative surgical excision to the date of local or distant recurrence or death.
Statistical methods
Data were analyzed using IBM SPSS Advanced Statistics version 20.0 (SPSS Inc., Chicago, IL). Chi-square test (Fisher's exact test) was used to examine the relation between qualitative variables. For quantitative data, comparison between two groups was done using Mann-Whitney test. Survival analysis was done using the Kaplan-Meier method and comparison between two survival curves was done using log-rank test. A p-value < 0.05 was considered significant.
Results
The mean age at the time of local recurrence was 60.1 ± 8.5 years. The median interval between nephrectomy and recurrence was 13.5 months (7-25 months). The median follow up time was 7.5 months (2-22 months). Table 1 shows the clinical characteristics of the primary tumors in the studied group of 22 patients. The main type of tumors was clear cell carcinoma (n = 17). Tumors were mainly on the left side. Nine patients had T3 and T4 tumors and 5 had nodal metastases. Local recurrence involved mainly the operative bed (n = 17); 4 of these patients had nodal recurrence as well. Eight tumors were irresectable ( Table 2) .
Advanced stage (III or IV), T3 or T4 tumors and tumors 10 cm or larger in largest diameter were significantly associated with shorter interval between nephrectomy and occurrence of recurrence (Table 3) . Table 4 shows the relation between interval to recurrence and clinical characteristics of 1ry tumor and statistical analysis categorized two groups of patients 615 months and >15 months. Stage T3 or T4 carries about 3 times the risk of interval to recurrence 615 months (OR: 3.3, 95% CI: 1.4-7.3). Interval to recurrence was significantly longer in patients in whom complete excision of the local recurrence was possible (18.9 ± 4.4 months) compared to cases with residual mass (13.2 ± 1.5 months, p = 0.023) and irresectable tumors (11.1 ± 2.7 months, p = 0.001) ( Table 4 ).
The surgical excision was divided to complete (n = 9) and not complete (n = 13) including cases with residual tumor and irresectable masses. Advanced disease stage and shorter interval to recurrence were associated with higher proportion of patients in whom complete excision was not possible (p 0.002, and <0.001, respectively) ( Table 4 ).
The median OS of the 22 patients was 15 months (95% CI: 4.4-25.6). The cumulative OS proportion at 1 year was 53.8%. The median DFS survival of the 22 patients was 10 months (95% CI: 4.5-15.5). The cumulative DFS proportion at 1 year was 37.7%. Overall survival was significantly better in patients with nodal recurrence only (p < 0.001), complete excision of the recurrence (p < 0.001) and interval from nephrectomy to recurrence >15 months (p = 0.016) ( Fig. 1) . Similarly, DFS was significantly better in these conditions ( Table 5) .
Discussion
In the current series of 22 patients with isolated local recurrence following radical nephrectomy for RCC, tumor recurrence was mainly in the operative bed (n = 17). Advanced stage (T3 or T4) carries 3.3 times the risk of shorter interval from nephrectomy to recurrence (OR: 3.3, 95% CI: 1.4-7.3). Surgical excision was complete in 9 patients, incomplete in 5 and impossible in 8 patients. Advanced disease stage and shorter interval to recurrence were associated with higher proportion of patients in whom complete excision was not possible (p 0.002, and <0.001, respectively). The median OS of the 22 patients was 15 months (95% CI: 4.4-25.6) and the median DFS survival was 10 months (95% CI: 4.5-15.5). Overall and DF survival were significantly better in patients with nodal recurrence only, complete excision of the recurrence and interval from nephrectomy to recurrence >15 months.
The study identified 22 cases among 626 cases (3.5%). This figure was relatively high compared to the most modern series where it was about 2% [16] . In fact, the actual proportion is less than this because some of the referred cases were operated on by surgeons outside NCI and Fayoum teaching hospital. This is because NCI is the main and first oncology center in Egypt and still considered the main oncology referral center for all Egyptian hospitals all over the republic.
The median interval between nephrectomy and recurrence was 13.5 months (7-25 months). Advanced stage was significantly associated with shorter interval. This was comparable to previous studies [11, 16, 17] . Itano et al. reported a mean time to metastasis of 1.6 years in 19 patients [11] . Master et al. detected isolated renal fossa recurrence after a mean interval of 17 months [16] .
In a multivariable logistic regression analysis, T stage > 1 was the independent factor for early recurrence [18] . After a median follow up of 42 months of 495 patients who underwent nephrectomy for RCC, Stephenson et al. found that the rate, time and site of relapse were associated with pathological stage [19] .
The risk of local recurrence in the current series was higher in stages T3 and T4. This was confirmed in previous studies [20, 21] . However, in studies of Schro¨dter et al., Itano et al., and Gogus et al. there was a considerable number of T1 and low risk T1 cases with local recurrence [9, 11, 22] . In the current series, overall and DFS were better in association with interval to recurrence >15 months. Schrodter et al. reported similar findings where time to recurrence was significantly longer and size of recurrence significantly smaller in surviving patients [9] . The management strategy in the current series was surgical excision where complete tumor excision was achieved in 9/ 22 patients (41%). Complete surgical excision was possible with earlier disease stage and longer interval to recurrence. Complete excision was associated with significantly higher overall and DFS survival. Median overall survival was 15 months in cases of complete excision vs. 6 months in cases with incomplete excision (p < 0.001). In the past, surgical treatment of local recurrences was associated with significant morbidity and mortality due to late diagnosis [15, 23] .
Margulis et al. reported median recurrence-free of 11 months in a group of 54 patients with isolated local recurrence after radical nephrectomy. They concluded that aggressive resection of recurrences resulted in long-lasting local control and higher survival [24] . In 16 patients, Sandhu et al. found 2 inoperable cases. Complete surgical excision was associated with prolonged disease-free survival [12] . Also, complete surgical resection was associated with improved survival in a series of 34 patients [25] .
Go¨g˘u¨s ß et al. proved that patients can benefit from aggressive surgical approach despite significant complications in such type of surgery [22] . The overall survival rate in this series was 53.8%. Esrig et al. reported 55% survival rate at 1 year after aggressive surgical approach in 11 patients [15] . In 30 patients with isolated fossa recurrence, Itano et al. reported a 5-year survival rate of 51% after extensive surgery [11] . Higher median survival of 23.5 months was reported by Tanguay et al. [26] .
In conclusion, isolated local recurrence after primary radical nephrectomy for RCC is more common with more advanced stages, where the interval to recurrence tends to be shorter. The management of these cases should be surgical, which was possible in nearly 60% of cases. Complete excision was possible with earlier stages and longer interval to recurrence and associated with better overall and disease free survival.
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